CLINICAL AND EPIDEMIOLOGICAL FEATURES OF PATIENTS WITH NON-SPECIFIC INTERSTITIAL PNEUMONIA
Keywords:
interstitial lung disease, nonspecific interstitial pneumonia, epidemiology, age, clinical picture, predictorsAbstract
Interstitial lung diseases (ILD) account for 10-15% of all lung diseases. The clinical and epidemiological characteristics of patients with NSIP remain not fully studied. Lung diseases consistently rank 3-4 in mortality not only in world statistics, but also in mortality statistics for Uzbekistan. Purpose of the study: To study the clinical, epidemiological, demographic characteristics of patients with NSIP in the Samarkand region for the period from 2020 to 2023. Materials and methods: We analyzed the medical records of 262 patients with interstitial lung disease who were hospitalized at SamGMO. Based on a multidisciplinary approach, taking into account the criteria of the international classification of diseases (ICD-10), patients diagnosed with NSIP and a comparison group, patients with COVID-19AP, were identified. Results: The total number of patients is 262. The first group is patients with NSIP 190 (72.5%) The second group is patients with COVID-19AP 72 (27.5%) and the control group 20 patients. Depending on the severity, each group was divided into subgroups IA-moderate 125 patients (65.8%), IB-severe 65 patients (34.2%), IIA-moderate 33 patients (45.8%) and IIB-severe 39 patients (54.2%) with NSIP and COVID-19AP, respectively. The study included patients in the age category from 18 to 90 years. Conclusion: Among patients with NSIP, men prevailed 145 (55.3%), 78% of patients were in the older age groups 45-59 (45%) and 60-74 (33%), respectively. 158 patients i.e. 60% are patients with moderate severity of the disease NSIP, in contrast to COVID-19AP, in which the severe course prevailed (40%, respectively).
References
Авдеев С.Н., Чикина С.Ю., Тюрин И.Е., Белевский А.С., Терпигорев С.А., Ананьева Л.П., Визель А.А., Болдина М.В., Демко И.В., Лещенко И.В., Трофименко И.Н., Киняйкин М.Ф., Степанян И.Э., Зайцева А.С., Петров Д.В. Хронические фиброзирующие интерстициальные заболевания легких с прогрессирующим фиброзным фенотипом: резолюция Междисциплинарного Совета экспертов. Пульмонология. 2021; 31 (4): 505–510. DOI: 10.18093/0869-0189-2021-31-4-505-510
Вершинина М.В. Идиопатические интерстициальные пневмонии.//Лечащий врач. 2013. № 1. С. 3 - 9.
Визель А.А. Саркоидоз: обзор работ последних лет // Пульмонология № 1. С. 83-89.
Дворецкий Л.И. Интерстициальные заболевания легких у пожилых. Пульмонология. 2014;(4):91-99.
Дворецкий Л.И. Качество жизни пожилого больного. // Consilium Medicum. 2009.№11. С.98-102.
Демура С.А., Коган Е.А., Пауков В.С. Патологическая репарация в зонах ниш стволовых клеток респираторных отделов легкого при идиопатическом легочном фиброзе. Пульмонология. 2015;25(3):350- 356.
Идиопатический легочный фиброз. Клинические рекомендации Минздрава РФ, 2016г. 44С.
Интерстициальные болезни легких. Под ред. Н.А. Мухина. Литтерра. 2007. 434 С.
Забозлаев Ф.Г., Кравченко Э.В., Галлямова А.Р., Летуновский Н.Н. Патологическая анатомия легких при новой коронавирусной инфекции (COVID-19). Предварительный анализ аутопсийных исследований. Клиническая практика. 2020;11(2): In Press.doi: 10.17816/ clinpract34849)
Xu W, Xiao Y, Liu H, Qin M, Zheng W, Shi J. Nonspecific interstitial pneumonia: clinical associations and outcomes. BMC Pulm Med. 2014 Nov 7;14:175. doi: 10.1186/1471-2466-14-175. PMID: 25380997; PMCID: PMC4236489.
Sebastiani M, Faverio P, Manfredi A, Cassone G, Vacchi C, Stainer A, Pozzi MR, Salvarani C, Pesci A, Luppi F. Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential. Biomedicines. 2020 Dec 26; 9(1):17.doi: 10.3390/biomedicines9010017. PMID: 33375368; PMCID: PMC7824155.
Teoh AKY, Corte TJ. Nonspecific Interstitial Pneumonia. Semin Respir Crit Care Med. 2020 Apr; 41(2):184-201.doi: 10.1055/s-0040-1708499. Epub 2020 Apr 12. PMID: 32279290.
Tomassetti S, Ryu JH, Piciucchi S, Chilosi M, Poletti V. Nonspecific Interstitial Pneumonia: What Is the Optimal Approach to Management? Semin Respir Crit Care Med. 2016 Jun; 37(3):378-94.doi: 10.1055/s-0036-1583176. Epub 2016 May 27. PMID: 27231862.
